tradingkey.logo
搜索

Co-Diagnostics Inc

CODX
添加自选
2.990USD
-0.090-2.92%
收盘 07/02, 13:00美东报价延迟15分钟
10.77M总市值
亏损市盈率 TTM

Co-Diagnostics Inc

2.990
-0.090-2.92%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-2.92%

5天

-2.29%

1月

-48.09%

6月

-46.22%

今年开始到现在

+1673.43%

1年

+979.42%

关键数据
3.010今开
3.400最高
1.00M成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
27.89%换手率
3.080昨收
2.930最低
2.29M成交额
亏损市盈率静
0.67市净率
0.00%股息率 TTM
-128.83%ROA
46.50052周最高
1.03量比
-37.64M净利润
3.60M总股本
-1054.6482每股收益TTM
2.91Beta
-154.38%ROE
1.26052周最低
15.26%振幅
-207.78%毛利率
10.77M总市值
-3.56回报/风险
13.05%风险率

TradingKey Co-Diagnostics Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Co-Diagnostics Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名122/204位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价30.00。中期看,股价处于上升通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Co-Diagnostics Inc评分

相关信息

行业排名
122 / 204
全市场排名
295 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Co-Diagnostics Inc亮点

亮点风险
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
业绩增长期
公司处于发展阶段,最新年度总收入622.49K美元
利润高增长
公司净利润处于行业前列,最新年度总收入622.49K美元
估值高估
公司最新PE估值-0.00,处于3年历史高位
机构减仓
最新机构持股248.15K股,环比减少39.01%
活跃度降低
近期活跃度降低,过去20天平均换手率-0.73

分析师目标

根据 2 位分析师
持有
评级
30.000
目标均价
+1171.19%
涨幅空间

Co-Diagnostics Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Co-Diagnostics Inc简介

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
公司代码CODX
公司Co-Diagnostics Inc
CEOEgan (Dwight H)
网址https://codiagnostics.com/

常见问题

Co-Diagnostics Inc(CODX)的当前股价是多少?

Co-Diagnostics Inc(CODX)的当前股价是 2.99。

Co-Diagnostics Inc的股票代码是什么?

Co-Diagnostics Inc的股票代码是CODX。

Co-Diagnostics Inc股票的52周最高点是多少?

Co-Diagnostics Inc股票的52周最高点是46.50。

Co-Diagnostics Inc股票的52周最低点是多少?

Co-Diagnostics Inc股票的52周最低点是1.26。

Co-Diagnostics Inc的市值是多少?

Co-Diagnostics Inc的市值是10.77M。

现在Co-Diagnostics Inc(CODX)的股票是买入、持有还是卖出?

根据分析师评级,Co-Diagnostics Inc(CODX)的总体评级为signal_hold,目标价格为30.00。

Co-Diagnostics Inc(CODX)股票的每股收益(EPS TTM)是多少

Co-Diagnostics Inc(CODX)股票的每股收益(EPS TTM)是-1057.64。